Bladder cancer combo trial pulled before it even started
Disease control
Terminated
This was a small early-stage trial testing a mix of three drugs (N-803, pembrolizumab, and enfortumab vedotin) for people with advanced bladder cancer who had not yet received any treatment. The goal was to see if the combination was safe and could slow cancer growth. However, th…
Phase: PHASE1 • Sponsor: Vadim S Koshkin • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC